Joe Muldoon leverages 30 years of experience, from technology start-up organizations to publicly traded multinational companies. He has worked with many high-growth entrepreneurial companies, occasionally serving as Angel Investor and CEO. Joe has advised select medical technology companies, including TGX Medical, Vasc-Alert, Trust Bearer Labs, and Geist Pharmaceuticals. Previously, he was President and CEO of FirstMile Technologies, a start-up broadband provider he led through its sale. Prior to that, he served as President of Brightpoint North America, a publicly traded Fortune 500 wireless company that grew to $750MM under his leadership. He has also held executive general management positions at MacMillan. Joe has a Bachelor of Science in Business from Indiana University’s Kelley School of Business.

With over 20 years of industry experience developing cardiovascular devices, Dr. Zelenkofske is currently Chief Medical Officer for SwanBio Therapeutics. He has led teams to regulatory approvals worldwide and led or participated in over a dozen NCE and sNDA approvals. Dr. Zelenkofske was previously CMO of Achillion Pharmaceuticals and Regado Biosciences and held senior leadership positions at Astra-Zeneca, Sanofi-Aventis, Boston Scientific and Novartis.

As Vice President of Regulatory Affairs and CMC, Dr. Putnam oversees the development and execution of FAST BioMedical’s regulatory strategy, injectable manufacturing, and quality systems. Dr Putnam is an expert in regulatory affairs and manufacturing with over eighteen years of product development experience. Dr. Putnam earned his Regulatory Affairs Certification (United States) in 2007 from the Regulatory Affairs Professional Society (RAPS) and is a routine contributor to the RAPS’ publication Fundamentals of US Regulatory Affairs. Dr. Putnam was previously the General Manager of Cardinal Health Regulatory Sciences where he led Cardinal Health’s scientific and regulatory consulting business unit which included more than 200+ regulatory affairs associates. As part of Cardinal Health Regulatory Sciences, Dr. Putnam played an integral role in the development and approval of dozens of pharmaceutical, biologic and medical device products. Dr. Putnam earned a PhD and MA in Organic Chemistry from Washington University in St. Louis where his research focused on drug discovery of therapeutic oligonucleotides.

Jeff Good is a Managing Director with Milestone Advisors, whose professional career reflects nearly 30 years of successful business management and executive leadership experience. In addition to finance and accounting, his expertise includes development and implementation of organizational growth strategies, capital formation, mergers and acquisitions, corporate governance and employee compensation and benefits. Jeff was an auditor for ten years with Ernst & Young LLP, later served as CFO for USA Group, Inc., and has since provided contract CFO and other advisory services to a number of early stage growth companies. He serves on the board and chairs the Audit Committee of Citizens Energy Group and is a board member and Treasurer for the Indiana Chapter of the Association for Corporate Growth. He graduated from the University of Notre Dame with High Honors in 1984 and is a member of the AICPA and Indiana CPA Society.

Dr. Meier has over 30 years experience in product development. During that time, he led the product development efforts of nine commercialized medical diagnostic systems and was responsible for the conceptual design and implementation of their spectroscopy and fluorescence-based detection systems. He has served in executive leadership positions with several companies including Biotage Inc, Argonaut Technologies, Camile Products, Synermed International, and American Monitor Corporation and has consulted with clients such as Beckman-Coulter, Baxter, and Olympus. Dr. Meier has several patents for medical diagnostic instruments and pharmaceutical process research instruments and holds a PhD in Electrical Engineering from Trinity College

As Director of Clinical and Biomedical Products, Ms. Reilly directs the start-up, execution and completion of all clinical studies for FAST BioMedical, including protocols, staff training, data analysis and reporting. She collaborates with the team on the engineering design and development of prototypes for our devices. She has over 10 years’ experience working with new medical device development. Ms. Reilly earned a Bachelor of Science Degree from Rose-Hulman Institute of Technology, and was recently received the Rose-Hulman Distinguished Young Alumni Award. She is an author on seven publications and holds six patents.